Individuals of any age considered likely to have a monogenic disorder |
Complexity of medical care (minimum two out of three) |
• Multiple organ systems involved and managed by 3 or more specialty units |
• Severe condition with high morbidity and mortality |
• Severe limitations on function and activities of daily living |
Appropriate for trio sequencing |
• Both biological parents available |
• Non-specific phenotype with a broad differential diagnosis |
• Possibility of blended phenotype |
Exclusion criteria |
Phenotypes which are typically multi-factorial or environmental-related |
Unrecognised novel phenotypes with no evidence-based gene list (e.g., orphan syndromes) better suited to gene discovery projects |
Prior sequencing of candidate genes (excepting genes in which variant types are poorly detected by exome sequencing, such as copy number variants, nucleotide repeat disorders, methylation testing or mitochondrially encoded variants) |
Individuals who have been evaluated by specialists for diagnostic purposes for more than 2 years |
Demographics |
Proposed for recruitment |
37 |
Excluded |
7 |
Reasons for exclusion |
Investigated > 2 years n = 2 |
|
Non-genetic more likely n = 1 |
|
Failed complexity criteria n = 3 |
|
Microarray finding explained phenotype n = 1 |
Males |
14 (46.7%) |
Females |
16 (53.3%) |
Median age at recruitment (range) |
21.5 months (4–650 months) |
Phenotypic category |
(see Supplementary Table 1 for details) |
Neurodevelopmental without dysmorphism |
11 (36.7%) |
Neurodevelopmental with dysmorphism |
9 (30%) |
Multiple congenital anomalies |
4 (13.3%) |
Failure to thrive with neurodevelopmental issues |
4 (13.3%) |
Failure to thrive with dysmorphism |
2 (6.7%) |